Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Mayo Clinic
PRIMARY OBJECTIVES:
I. Determine the levels of prostate cancer-derived extracellular vesicles pre- and post-RP.
II. Determine the correlation between levels of prostate cancer-derived extracellular vesicles and PSA.
OUTLINE: This is an observational study. Participants are assigned to 1 of 2 cohorts.
COHORT I (RADICAL PROSTATECTOMY): Prostate cancer patients undergo blood and urine sample collection on study. Patients' medical records are also reviewed.
COHORT II (NEOADJUVANT): Prostate cancer patients undergo blood and urine sample collection throughout the study. Patients' medical records are also reviewed.
COHORT III (NEGATIVE CONTROLS): Female urology clinic patients and female volunteers undergo blood and urine sample collection on study.
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
PROSTATE CANCER PATIENTS:
* Age 18+
* Able to give informed consent
* Patients with prostate cancer
* Patients treated with primary prostatectomy
* The focus will be on high-risk patients with at least one of either criterion:
* PSA \>= 20 ng/ml
* AND/OR Gleason \>= 8
* AND/OR clinical stage \>= T3
FEMALE CONTROL PATIENTS:
* Age 18+
* Able to give informed consent
You may not be if
PROSTATE CANCER PATIENTS:
* Unable or unwilling to provide informed consent
* Metastatic prostate cancer - defined evidence of metastatic disease on pre-procedural testing
FEMALE CONTROL PATIENTS:
* Unable or unwilling to provide informed consent
Clareo Health | Determination of Baseline Levels for Prostate Cancer-Derived Extracellular Vesicles Following Local Treatment of Prostate Cancer
